Q Fever News and Research

RSS

Researchers reveal potential therapeutic treatment for alphavirus infections

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment for the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus (RRV) and Chikungunya Virus (CHIKV).

8 Sep 2016

Early life exposure to antibiotics found to increase allergy risk later in life

An analysis of almost 400,000 people has shown that exposure to antibiotics in early life is linked to an increased risk of developing allergies later in life.

8 Sep 2016

New tool could help reduce antibiotic prescribing to children with cough and RTIs

Respiratory tract infections (RTI) with cough are the most common reason children are prescribed antibiotics by their doctors, but up to a third of prescriptions may be unnecessary.

8 Sep 2016

EarlySense-powered sensor reveals sleep quality scores for 4 European countries

EarlySense, the market leader in contact-free continuous monitoring solutions, released today sleep scores gathered from a sample of 900 Europeans using an EarlySense-powered sleep sensor for six months. Data recordings from more than 20,000 nights were analyzed.

8 Sep 2016

New blood test helps identify bacterial infection in infants with fever

A blood test used to measure patterns of ribonucleic acid (RNA) expression can help determine if fever in infants under 2 months old is caused by bacterial or viral infection, according to a preliminary study recently published in the Journal of the American Medical Association.

8 Sep 2016

Researchers isolate cord blood factor that helps fight harmful inflammation

A factor found in umbilical cord blood could become the basis for developing a new therapy to fight harmful inflammation, University of Utah School of Medicine researchers report.

7 Sep 2016

Dengue vaccine may worsen infections if used in areas with low rates of disease

The world's only licensed vaccine for dengue may worsen subsequent dengue infections if used in areas with low rates of dengue infection, suggests new research.

6 Sep 2016

Early life use of antibiotics linked to higher risk of developing allergies later in life

Research presented today (6 September, 2016) at this year's European Respiratory Society International Congress in London, UK shows that exposure to antibiotics early in life is related to increased risk of developing allergies later in life.

6 Sep 2016

New mathematical model could help predict potential outbreaks of Ebola and Lassa fever

Potential outbreaks of diseases such as Ebola and Lassa fever may be more accurately predicted thanks to a new mathematical model developed by researchers at the University of Cambridge.

2 Sep 2016

Early diagnosis and treatment key to surviving sepsis

Every minute, someone comes into a hospital emergency department in the United States with sepsis, a life-threatening over-response to infection that damages tissues and organs.

2 Sep 2016

Approved dengue vaccine may increase infection in certain settings, research suggests

The only approved vaccine for dengue may actually increase the incidence of dengue infections requiring hospitalization rather than preventing the disease if health officials aren't careful about where they vaccinate, new public health research published Sept. 2 in Science suggests.

1 Sep 2016

Mayo Clinic offers CDC’s Zika virus screening test

Mayo Clinic will offer the Zika virus antibody test developed by the Centers for Disease Control and Prevention.

1 Sep 2016

Official statistics may underestimate size of Zika epidemic, study suggests

A study supported by FAPESP and coordinated by researchers at the São José do Rio Preto Medical School in São Paulo State, Brazil, suggests official statistics may underestimate the size of the epidemic caused by Zika virus.

1 Sep 2016

Pre-travel consultation can help international travelers to prepare for trip

International tourism exceeds 1.2 billion persons each year, with more than 20 percent of travelers reporting some type of illness.

31 Aug 2016

Respiratory viral infection triggering asthma attack in children linked to treatment failure

The results of a study conducted by Dr. Francine Ducharme, Professor in the Departments of Pediatrics and Social and Preventive Medicine at the University of Montreal, published in the medical journal The Lancet Respiratory Medicine, confirm that respiratory viral detection, not child's age, explains the high rate of hospitalization for asthma attacks in children under six.

30 Aug 2016

New research shows female mosquitoes can pass Zika virus to their offsprings

New research from The University of Texas Medical Branch in Galveston has shown that female Aedes aegypti mosquitoes can pass the Zika virus to their eggs and offspring.

30 Aug 2016

Cases of rotavirus infections fall by 84% thanks to vaccination

Figures published by Public Health England have shown that the number of diagnosed Rotavirus cases, a highly infectious virus which may cause vomiting and diarrhoea, have dropped by 84% since the introduction of a vaccine to the national childhood immunisation schedule in July 2013.

29 Aug 2016

Leading Chikungunya vaccine in clinical trial phase 2

With the first patient vaccinated, a Phase 2 clinical trial of a promising prophylactic vaccine candidate against Chikungunya fever has now commenced. The product is the most advanced Chikungunya vaccine candidate globally and is developed by the Austrian biotech company Themis Bioscience GmbH.

29 Aug 2016

Biostatisticians project nearly 400 non-travel Zika cases in Florida by end of summer

Nearly 400 non travel-related Zika infections will occur in Florida before the end of the summer, according to new projections by biostatisticians at the University of Florida and other institutions.

27 Aug 2016

Revised FDA guidance recommends universal testing of entire blood supply for Zika virus in the U.S.

As a further safety measure against the emerging Zika virus outbreak, today the U.S. Food and Drug Administration issued a revised guidance recommending universal testing of donated Whole Blood and blood components for Zika virus in the U.S. and its territories.

27 Aug 2016